InMed Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

InMed Pharmaceuticals

24/09/2021 14:31

* InMed Pharmaceuticals Inc  INM.OQ  reported a quarterly
adjusted loss of 41 cents​​ per share for the quarter ended in
June. The lone analyst forecast for the quarter was for a loss
of 34 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* InMed Pharmaceuticals Inc's reported EPS for the quarter was a
loss of 41 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* InMed Pharmaceuticals Inc shares had fallen by 42.5% this
quarter and lost 44.4% so far this year.
* The company reported a quarterly loss of $3.26 million.
* Wall Street's median 12-month price target for InMed
Pharmaceuticals Inc is $11.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated September 24 at 01:31 p.m.
 ​All figures in US dollars unless otherwise stated